Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Invested Capital (2021 - 2025)

Historic Invested Capital for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $5.0 billion.

  • Roivant Sciences' Invested Capital fell 1014.72% to $5.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.0 billion, marking a year-over-year decrease of 1014.72%. This contributed to the annual value of $5.2 billion for FY2025, which is 2459.5% down from last year.
  • According to the latest figures from Q4 2025, Roivant Sciences' Invested Capital is $5.0 billion, which was down 1014.72% from $4.8 billion recorded in Q3 2025.
  • Roivant Sciences' Invested Capital's 5-year high stood at $7.0 billion during Q4 2023, with a 5-year trough of $1.7 billion in Q3 2023.
  • Over the past 5 years, Roivant Sciences' median Invested Capital value was $2.5 billion (recorded in 2021), while the average stood at $3.7 billion.
  • As far as peak fluctuations go, Roivant Sciences' Invested Capital plummeted by 2808.19% in 2022, and later surged by 28773.05% in 2023.
  • Quarter analysis of 5 years shows Roivant Sciences' Invested Capital stood at $2.5 billion in 2021, then decreased by 26.48% to $1.8 billion in 2022, then soared by 287.73% to $7.0 billion in 2023, then fell by 20.78% to $5.5 billion in 2024, then fell by 10.15% to $5.0 billion in 2025.
  • Its Invested Capital was $5.0 billion in Q4 2025, compared to $4.8 billion in Q3 2025 and $4.8 billion in Q2 2025.